Original article
-
Issue: Vol. 21 No. 1 (2023): Blood Transfusion 1-2023 (January-February)
Publication Date: 2022-04-19
Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin®) in paediatric patients under 6 years of age with severe von Willebrand disease
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2022-04-19
Immuno-hematological monitoring after allogeneic stem cell transplantation: a single-center, prospective study of 104 patients
-
Issue: Vol. 21 No. 1 (2023): Blood Transfusion 1-2023 (January-February)
Publication Date: 2022-03-11
Multivariable statistical models to predict red cell transfusion in elective surgery
-
Issue: Vol. 21 No. 2 (2023): Blood Transfusion 2-2023 (March-April)
Publication Date: 2022-03-07
Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2022-02-28
Anti-SARS-CoV-2 vaccination does not influence anticoagulation levels in stable long-term warfarin treatment
-
Issue: Vol. 21 No. 1 (2023): Blood Transfusion 1-2023 (January-February)
Publication Date: 2022-02-28
Stored whole blood transfusion initiates serum amyloid A activation monitored by real-time dynamic imaging
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2022-02-28
Prevalence of ABO and RhD blood group phenotypes in the Croatian population and in patients with severe COVID-19 in Croatia
-
Issue: Vol. 21 No. 2 (2023): Blood Transfusion 2-2023 (March-April)
Publication Date: 2022-02-28
Cryopreserved platelets and amotosalen-treated plasma in an experimental clot formation set-up
-
Issue: Vol. 21 No. 2 (2023): Blood Transfusion 2-2023 (March-April)
Publication Date: 2022-02-16
Whole transcriptome analysis of platelet concentrates during storage
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2022-02-11
3D analysis of CROMER (DAF) and a new antigen CRAG
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2022-02-04
SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain)
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2022-02-01
Assessing quality of blood components derived from whole blood treated with riboflavin and ultraviolet light and separated with a fully automated device
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2022-02-01
Hepatitis E infection in adults with primary immunodeficiency with or without immunoglobulin replacement therapy
-
Issue: Blood Transfusion - 4 2022 (July-August)
Publication Date: 2022-01-22
ABO antibody titres: a multisite comparative study of equivalency and reproducibility for automated solid-phase and haemagglutination titration, and manual dilution with gel column agglutination technology
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2022-01-21
SARS-CoV-2 and post-donation information: a one-year experience of the French haemovigilance network
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2021-12-17
Associations of anaemia and race with peripartum transfusion in three United States datasets
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2021-12-13
Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19
-
Issue: Blood Transfusion - 4 2022 (July-August)
Publication Date: 2021-11-29
Characterising differences in red blood cell usage patterns between healthcare sectors in South Africa: 2014-2019
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2021-11-29
Analysis of the molecular mechanism and pedigree investigation of para-Bombay phenotype caused by combined mutations at position h649 and h768 of FUT1 gene
-
Issue: Blood Transfusion - 4 2022 (July-August)
Publication Date: 2021-11-29
Blood supply, transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemic
-
Issue: Blood Transfusion - 5 2022 (September-October)
Publication Date: 2021-11-29
Expanding restrictive transfusion evidence in surgical practice: a multicentre, prospective cohort study
-
Issue: Blood Transfusion - 6 2022 (November-December)
Publication Date: 2021-11-11
Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism
-
Issue: Blood Transfusion - 4 2022 (July-August)
Publication Date: 2021-10-15
Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial
-
Issue: Blood Transfusion - 1 2022 (January-February)
Publication Date: 2021-10-15
Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project
-
Issue: Blood Transfusion - 4 2022 (July-August)
Publication Date: 2021-09-22
Vasovagal reactions in whole blood and apheresis donors: a cross-sectional study on donor haemovigilance data from 2016 to 2019 in Italy
-
Issue: Vol. 21 No. 1 (2023): Blood Transfusion 1-2023 (January-February)
Publication Date: 2021-09-03
Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach
-
Issue: Blood Transfusion - 5 2021 (September-October)
Publication Date: 2021-08-05
A nationwide survey of clinical use of blood in Italy
-
Issue: Blood Transfusion - 6 2021 (November-December)
Publication Date: 2021-08-04
Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity
-
Issue: Blood Transfusion - 3 2022 (May-June)
Publication Date: 2021-08-03
Impact of blood source and component manufacturing on neurotrophin content and in vitro cell wound healing
-
Issue: Blood Transfusion - 3 2022 (May-June)
Publication Date: 2021-08-02
Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light